Our paclitaxel history

Cook Medical’s history with paclitaxel spans nearly 30 years

Zilver^® PTX^® started in the coronary and landed in the SFA.

15 years of global studies

• >1,000 patients included in pre-market clinical studies to support US regulatory approval.
• >2,500 patients included in pre- and post-market clinical studies.
• >300,000 Zilver PTX stents used to treat patients with PAD.
• Tested in a broad range of lesions.